Accuray Inc.’s (NASDAQ:ARAY) recent agreement with RaySearch Laboratories around an extended alliance, is a major step toward ...

The collaboration combines Accuray's advanced photon-based radiation therapy platforms and imaging capabilities with RaySearch's treatment planning and workflow software to enable online adaptive ...

An update from RaySearch Laboratories AB ( ($SE:RAY.B) ) is now available. RaySearch Laboratories AB and U.S.-based Accuray Incorporated have signed a definitive agreement to expand their ...

Accuray Incorporated ARAY is well-poised for growth in the coming quarters, courtesy of continued product order momentum. The optimism, led by decent performance in the emerging markets in the fourth ...

Accuray (ARAY) and RaySearch Laboratories agreed to combine Accuray's radiation therapy platforms with RaySearch's RayStation treatment planning software to boost the adoption of online adaptive ...

"Total revenue was approximately $105 million, up 3% sequentially, but down 7% year-over-year." (President, CEO & Director Stephen LaNeve) "In the third quarter, we had product shipments planned to ...

Impressive revenue growth remains elusive for Accuray despite the potential in China, and there are ongoing challenges with profitability, competition, and market scale. The last quarter's results ...

Accuray's fiscal first quarter results weren't far off of expectations, and the book-to-bill was strong as the company logged more new system orders. While gross orders were healthy, net orders and ...

Accuray Incorporated () has held its Q4 earnings call. Read on for the main highlights of the call. Summer Sale - Claim 70% Off TipRanks. Unlock powerful investing tools with TipR ...

RaySearch Laboratories AB (publ) and Accuray Incorporated (NASDAQ: ARAY) today announced that they had entered into a definitive agreement providing for an expanded collaboration aimed at accelerating ...